文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

纳米颗粒在慢性肾脏病诊断与治疗中的应用。

Application of nanoparticles in the diagnosis and treatment of chronic kidney disease.

作者信息

Yang Kaibi, Shang Yiwei, Yang Nan, Pan Shujun, Jin Juan, He Qiang

机构信息

Urology and Nephrology Center, Department of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.

Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, China.

出版信息

Front Med (Lausanne). 2023 Apr 17;10:1132355. doi: 10.3389/fmed.2023.1132355. eCollection 2023.


DOI:10.3389/fmed.2023.1132355
PMID:37138743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10149997/
Abstract

With the development of nanotechnology, nanoparticles have been used in various industries. In medicine, nanoparticles have been used in the diagnosis and treatment of diseases. The kidney is an important organ for waste excretion and maintaining the balance of the internal environment; it filters various metabolic wastes. Kidney dysfunction may result in the accumulation of excess water and various toxins in the body without being discharged, leading to complications and life-threatening conditions. Based on their physical and chemical properties, nanoparticles can enter cells and cross biological barriers to reach the kidneys and therefore, can be used in the diagnosis and treatment of chronic kidney disease (CKD). In the first search, we used the English terms "Renal Insufficiency, Chronic" [Mesh] as the subject word and terms such as "Chronic Renal Insufficiencies," "Chronic Renal Insufficiency," "Chronic Kidney Diseases," "Kidney Disease, Chronic," "Renal Disease, Chronic" as free words. In the second search, we used "Nanoparticles" [Mesh] as the subject word and "Nanocrystalline Materials," "Materials, Nanocrystalline," "Nanocrystals," and others as free words. The relevant literature was searched and read. Moreover, we analyzed and summarized the application and mechanism of nanoparticles in the diagnosis of CKD, application of nanoparticles in the diagnosis and treatment of renal fibrosis and vascular calcification (VC), and their clinical application in patients undergoing dialysis. Specifically, we found that nanoparticles can detect CKD in the early stages in a variety of ways, such as breath sensors that detect gases and biosensors that detect urine and can be used as a contrast agent to avoid kidney damage. In addition, nanoparticles can be used to treat and reverse renal fibrosis, as well as detect and treat VC in patients with early CKD. Simultaneously, nanoparticles can improve safety and convenience for patients undergoing dialysis. Finally, we summarize the current advantages and limitations of nanoparticles applied to CKD as well as their future prospects.

摘要

随着纳米技术的发展,纳米颗粒已被应用于各个行业。在医学领域,纳米颗粒已被用于疾病的诊断和治疗。肾脏是排泄废物和维持内环境平衡的重要器官;它过滤各种代谢废物。肾功能障碍可能导致体内多余的水分和各种毒素积聚而无法排出,从而引发并发症并危及生命。基于其物理和化学性质,纳米颗粒可以进入细胞并穿过生物屏障到达肾脏,因此可用于慢性肾脏病(CKD)的诊断和治疗。在第一次检索中,我们使用英文术语“Renal Insufficiency, Chronic”[医学主题词]作为主题词,并使用“Chronic Renal Insufficiencies”、“Chronic Renal Insufficiency”、“Chronic Kidney Diseases”、“Kidney Disease, Chronic”、“Renal Disease, Chronic”等术语作为自由词。在第二次检索中,我们使用“Nanoparticles”[医学主题词]作为主题词,并使用“Nanocrystalline Materials”、“Materials, Nanocrystalline”、“Nanocrystals”等作为自由词。对相关文献进行了检索和阅读。此外,我们分析并总结了纳米颗粒在CKD诊断中的应用及机制、纳米颗粒在肾纤维化和血管钙化(VC)诊断与治疗中的应用以及它们在透析患者中的临床应用。具体而言,我们发现纳米颗粒可以通过多种方式在早期检测CKD,例如检测气体的呼吸传感器和检测尿液的生物传感器,并且可以用作造影剂以避免肾脏损伤。此外,纳米颗粒可用于治疗和逆转肾纤维化,以及检测和治疗早期CKD患者的VC。同时,纳米颗粒可以提高透析患者的安全性和便利性。最后,我们总结了纳米颗粒应用于CKD的当前优势和局限性以及它们的未来前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/10149997/167b69b05401/fmed-10-1132355-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/10149997/00505c8c3561/fmed-10-1132355-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/10149997/167b69b05401/fmed-10-1132355-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/10149997/00505c8c3561/fmed-10-1132355-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/10149997/167b69b05401/fmed-10-1132355-g002.jpg

相似文献

[1]
Application of nanoparticles in the diagnosis and treatment of chronic kidney disease.

Front Med (Lausanne). 2023-4-17

[2]
Preparation of Gold Nanoparticles and Its Effect on Autophagy and Oxidative Stress in Chronic Kidney Disease Cell Model.

J Nanosci Nanotechnol. 2021-2-1

[3]
Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.

Toxins (Basel). 2021-4-10

[4]
Mitochondria and vascular calcification in chronic kidney disease: Lessons learned from the past to improve future therapy.

J Cell Physiol. 2022-12

[5]
Arterial accelerated aging in dialysis patients: the clinical impact of vascular calcification.

Curr Vasc Pharmacol. 2009-7

[6]
Vascular calcification in skin and subcutaneous tissue in patients with chronic and end-stage kidney disease.

BMC Nephrol. 2020-7-16

[7]
FGF23 Actions in CKD-MBD and other Organs During CKD.

Curr Med Chem. 2023

[8]
Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.

Adv Chronic Kidney Dis. 2011-3

[9]
Vascular calcification in long-term kidney transplantation.

Nephrology (Carlton). 2014-4

[10]
Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis.

J Control Release. 2022-6

引用本文的文献

[1]
Research and Application Prospect of Nanomedicine in Kidney Disease: A Bibliometric Analysis From 2003 to 2024.

Int J Nanomedicine. 2025-3-12

[2]
Advancements in Nanomedicine for the Diagnosis and Treatment of Kidney Stones.

Int J Nanomedicine. 2025-2-3

[3]
Green metal nanotechnology in monogastric animal health: current trends and future prospects - A review.

Anim Biosci. 2025-1

本文引用的文献

[1]
Capacitance-Based Biosensor for the Measurement of Total Loss of L-Amino Acids in Human Serum during Hemodialysis.

ACS Sens. 2022-11-25

[2]
Farnesylthiosalicylic Acid-Loaded Albumin Nanoparticle Alleviates Renal Fibrosis by Inhibiting Ras/Raf1/p38 Signaling Pathway.

Int J Nanomedicine. 2021

[3]
Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis.

Molecules. 2021-8-20

[4]
Improving kidney targeting: The influence of nanoparticle physicochemical properties on kidney interactions.

J Control Release. 2021-6-10

[5]
Novel Application of Magnetite Nanoparticle-Mediated Vitamin D3 Delivery for Peritoneal Dialysis-Related Peritoneal Damage.

Int J Nanomedicine. 2021-3-11

[6]
Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine.

Chem Soc Rev. 2021-5-7

[7]
Nanoparticle-Mediated Delivery of Emodin via Colonic Irrigation Attenuates Renal Injury in 5/6 Nephrectomized Rats.

Front Pharmacol. 2021-1-21

[8]
Adsorptivity of cationic cellulose nanocrystals for phosphate and its application in hyperphosphatemia therapy.

Carbohydr Polym. 2021-3-1

[9]
Safe Nanoparticles: Are We There Yet?

Int J Mol Sci. 2020-12-31

[10]
The trends in nanomaterial-based biosensors for detecting critical biomarkers in stroke.

Clin Chim Acta. 2021-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索